ATE505508T1 - Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung - Google Patents

Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung

Info

Publication number
ATE505508T1
ATE505508T1 AT04748676T AT04748676T ATE505508T1 AT E505508 T1 ATE505508 T1 AT E505508T1 AT 04748676 T AT04748676 T AT 04748676T AT 04748676 T AT04748676 T AT 04748676T AT E505508 T1 ATE505508 T1 AT E505508T1
Authority
AT
Austria
Prior art keywords
delivery device
active substance
medicinal delivery
releasing
active compound
Prior art date
Application number
AT04748676T
Other languages
English (en)
Inventor
Henny Bruinewoud
Johannes Keurentjes
Maria Kemmere
Original Assignee
Dolphys Medical B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dolphys Medical B V filed Critical Dolphys Medical B V
Application granted granted Critical
Publication of ATE505508T1 publication Critical patent/ATE505508T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • B29C71/02—Thermal after-treatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • B29C71/04—After-treatment of articles without altering their shape; Apparatus therefor by wave energy or particle radiation, e.g. for curing or vulcanising preformed articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/0822—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using IR radiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00—Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/0261—Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould using ultrasonic or sonic vibrations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Thermal Sciences (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
AT04748676T 2003-06-23 2004-06-23 Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung ATE505508T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1023720A NL1023720C2 (nl) 2003-06-23 2003-06-23 Werkwijze voor het wijzigen van de transporteigenschappen van een materiaal, werkwijze voor het vrijmaken van een werkstof uit een implantaat, evenals implantaat met werkstof.
PCT/NL2004/000446 WO2004113422A2 (en) 2003-06-23 2004-06-23 Drug delivery device comprising an active compound and method for releasing an active compound from a drug delivery device

Publications (1)

Publication Number Publication Date
ATE505508T1 true ATE505508T1 (de) 2011-04-15

Family

ID=33536502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748676T ATE505508T1 (de) 2003-06-23 2004-06-23 Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung

Country Status (9)

Country Link
US (1) US20050025830A1 (de)
EP (1) EP1636295B1 (de)
JP (1) JP2007521261A (de)
CN (1) CN1809607B (de)
AT (1) ATE505508T1 (de)
CA (1) CA2530003A1 (de)
DE (1) DE602004032232D1 (de)
NL (1) NL1023720C2 (de)
WO (1) WO2004113422A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
ES2179646T3 (es) * 1998-04-27 2003-01-16 Surmodics Inc Revestimiento que libera un agente bioactivo.
US7097850B2 (en) * 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US20030232087A1 (en) * 2002-06-18 2003-12-18 Lawin Laurie R. Bioactive agent release coating with aromatic poly(meth)acrylates
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
US7541048B2 (en) * 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents
WO2007143796A1 (en) 2006-06-15 2007-12-21 Seagull Ip Pty Ltd A delivery system and process
AU2014200299B2 (en) * 2006-06-15 2015-04-02 Polypharma Pty Ltd A delivery system and process
EP2046286A1 (de) * 2006-08-01 2009-04-15 Dolphys Technologies B.V. Arzneiabgabevorrichtung mit einer pharmazeutisch oder biologisch wirksamen komponente und einer infrarot-absorbierenden verbindung
US20080228151A1 (en) * 2007-02-28 2008-09-18 Jie Zhang Transdermal drug delivery with controlled heat for treating musculoskeletal pain and/or inflammation
WO2008150995A2 (en) * 2007-06-01 2008-12-11 Zars Pharma, Inc. Transdermal drug delivery systems for delivering anti-inflammatory drugs
US9107815B2 (en) 2008-02-22 2015-08-18 Allergan, Inc. Sustained release poloxamer containing pharmaceutical compositions
WO2010011327A2 (en) * 2008-07-24 2010-01-28 Children's Medical Center Corporation Radiative heating for drug delivery and other applications
US20110212163A1 (en) * 2008-07-24 2011-09-01 Children's Medical Center Corporation Magnetic heating for drug delivery and other applications
WO2010011326A2 (en) * 2008-07-24 2010-01-28 Children's Medical Center Corporation Heating of polymers-and other materials using radiation for drug delivery and other applications
US20120035531A1 (en) * 2009-02-10 2012-02-09 President And Fellows Of Harvard College On-demand and reversible drug release by external cue
EP2732832A3 (de) 2012-11-14 2015-07-01 Universitair Medisch Centrum Groningen (UMCG) Arzneimittelabgabevorrichtung mit einem Wirkstoff und einem wärmeempfindlichen Polymermaterial
CA3004849C (en) 2015-11-16 2024-06-11 Georges Gaudriault A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
JP7013465B2 (ja) * 2016-12-08 2022-01-31 アール．ピー．シェーラー テクノロジーズ、エルエルシー 制御された環境におけるソフトカプセルの加速乾燥
US11083692B2 (en) 2017-04-05 2021-08-10 University Of South Carolina Ultrasonic cavitation enabled tuning of persistent micelles

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2340111A (en) * 1942-07-03 1944-01-25 Gen Electric Process for removing cations from liquid media
US2340110A (en) * 1942-07-03 1944-01-25 Gen Electric Process for removing cations from liquid media
US2533635A (en) * 1947-09-26 1950-12-12 Monsanto Chemicals Printing textile fabrics with a dye paste comprising a styrene-maleic anhydride copolymer cross-linked with divinyl benzene
BE506629A (de) * 1950-10-25
US2703316A (en) * 1951-06-05 1955-03-01 Du Pont Polymers of high melting lactide
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US3700643A (en) * 1970-09-02 1972-10-24 Union Carbide Corp Radiation-curable acrylate-capped polycaprolactone compositions
BE758156R (fr) * 1970-05-13 1971-04-28 Ethicon Inc Element de suture absorbable et sa
US3839297A (en) * 1971-11-22 1974-10-01 Ethicon Inc Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US3940351A (en) * 1974-07-02 1976-02-24 The B. F. Goodrich Company Polymerization of carboxylic acid monomers and alkyl acrylate esters in chlorofluoroethane
US4062817A (en) * 1977-04-04 1977-12-13 The B.F. Goodrich Company Water absorbent polymers comprising unsaturated carboxylic acid, acrylic ester containing alkyl group 10-30 carbon atoms, and another acrylic ester containing alkyl group 2-8 carbon atoms
US4243775A (en) * 1978-11-13 1981-01-06 American Cyanamid Company Synthetic polyester surgical articles
US4137921A (en) * 1977-06-24 1979-02-06 Ethicon, Inc. Addition copolymers of lactide and glycolide and method of preparation
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
US4779806A (en) * 1984-07-23 1988-10-25 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
US4767402A (en) * 1986-07-08 1988-08-30 Massachusetts Institute Of Technology Ultrasound enhancement of transdermal drug delivery
US4830855A (en) * 1987-11-13 1989-05-16 Landec Labs, Inc. Temperature-controlled active agent dispenser
US5767222A (en) * 1988-08-08 1998-06-16 Chronopol, Inc. Degradable polydioxaneone-based materials
JP2958103B2 (ja) * 1989-12-12 1999-10-06 エーザイ株式会社 プラズマ照射固形製剤
US5034488A (en) * 1990-01-11 1991-07-23 Gaf Chemicals Corporation Slurry polymerization of crosslinked maleic anhydride-alkyl vinyl ether copolymers in a solvent system comprising a carboxylic acid ester and a saturated hydrocarbon
US5076983A (en) * 1990-07-16 1991-12-31 E. I. Du Pont De Nemours And Company Polyhydroxy acid films
US5034486A (en) * 1990-08-09 1991-07-23 Gaf Chemicals Corporation Terpolymers of maleic anhydride, C1 -C5 alkyl vinyl ether and a C12 -C14 alpha-olefin, and crosslinked products thereof
US5034487A (en) * 1990-08-09 1991-07-23 Gaf Chemicals Corporation Process for making copolymers of maleic anhydride and a C1 -C4 alkyl vinyl ether having a high specific viscosity
US5580573A (en) * 1991-02-01 1996-12-03 E. R. Squibb And Sons, Inc. Temperature activated controlled release
CN1067251A (zh) * 1991-05-25 1992-12-23 上海科学技术大学 药物缓释型水凝胶膜的合成方法
WO1993012160A1 (en) * 1991-12-19 1993-06-24 Mitsui Toatsu Chemicals, Inc. Polyhydroxy carboxylic acid and production thereof
US5417983A (en) * 1992-02-19 1995-05-23 Sagami Chemical Research Center Drug release controlling material responsive to changes in temperature
US5288814A (en) * 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
JP3167057B2 (ja) * 1993-02-19 2001-05-14 日本化薬株式会社 温度応答型ハイドロゲル
US6041253A (en) * 1995-12-18 2000-03-21 Massachusetts Institute Of Technology Effect of electric field and ultrasound for transdermal drug delivery
US5947921A (en) * 1995-12-18 1999-09-07 Massachusetts Institute Of Technology Chemical and physical enhancers and ultrasound for transdermal drug delivery
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
GB9702277D0 (en) * 1997-02-04 1997-03-26 Innes John Centre Modified electrodes and their use
AU5154000A (en) * 1999-05-19 2000-12-05 Brigham Young University Stabilization and acoustic activation of polymeric micelles for drug delivery
US6613355B2 (en) * 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US6740108B1 (en) * 2001-04-05 2004-05-25 Urologix, Inc. Thermal treatment catheter having preferential asymmetrical heating pattern
WO2003017972A2 (en) * 2001-08-27 2003-03-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers)

Also Published As

Publication number Publication date
EP1636295A2 (de) 2006-03-22
US20050025830A1 (en) 2005-02-03
DE602004032232D1 (de) 2011-05-26
WO2004113422A3 (en) 2005-03-03
CN1809607B (zh) 2012-03-21
NL1023720C2 (nl) 2004-12-28
CN1809607A (zh) 2006-07-26
WO2004113422A2 (en) 2004-12-29
EP1636295B1 (de) 2011-04-13
JP2007521261A (ja) 2007-08-02
CA2530003A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
ATE505508T1 (de) Arzneistoffzufuhrvorrichtung, die einen wirkstoff enthält, und verfahren zur freisetzung eines wirkstoffs aus einer arzneistoffzufuhrvorrichtung
BRPI0412798A (pt) uso de uma combinação de um antagonista de fator de crescimento endotelial vascular e um agente antiproliferativo, método de inibir ou reduzir o crescimento de tumor, composição farmacêutica, uso de uma combinação de um antagonista de vegf e um agente quimioterapêutico, e, artigo de fabricação
ATE295155T1 (de) Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
ATE307611T1 (de) Flüssiges hochvisköses system mit gesteuerter freisetzung und medizinische oder chirurgische vorrichtung
ATE470433T1 (de) Partikel mit kern aus calciumphosphat- nanopartikeln, biomolekül und gallensäure, herstellungsverfahren und therapeutische verwendung
BR0312887A (pt) Forma de dosagem farmacêutica de múltiplos componentes
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
ATE463266T1 (de) Vaskuläre biologisch abbaubare vorrichtung enthaltend einen ph-puffer
EP1781350A4 (de) Verfahren zur herstellung von beschichteten medizinischen vorrichtungen
DE602005012289D1 (de) Abgabevehikel mit nanoteilchen
MX2010004366A (es) Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
DK0740650T3 (da) Codrugs som metode til styret transport af lægemiddel
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
UA106631C2 (uk) Композиції з контрольованим вивільненням
ATE423578T1 (de) Medizinprodukt mit einem biologischen wirkstoff
MX2007007099A (es) Implante formado in situ para animales.
WO2006137856A3 (en) Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
ATE522204T1 (de) Beschichtete pellets
BRPI0912230A2 (pt) Método para encapsular agentes biologicamente ativos em um carreador particulado, carreador particulado, e, composição farmacêutica
ATE367803T1 (de) Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung
WO2010019611A3 (en) Bridged polycyclic compound based compositions for topical and oral applications
MXPA04003596A (es) Dispositivo de liberacion de substancias.
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties